Stay updated on Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T13:35:23.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The error page’s footer now displays site revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-11T14:11:13.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the full study details with a minimal error screen. This indicates the ClinicalTrials.gov record for NCT03220477 is not accessible at this time.
    Difference
    19%
    Check dated 2026-09-20T20:08:03.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The study page now includes new related topic links under MedlinePlus Genetics, including Lung cancer. These additions provide quick access to educational resources related to the condition.
    Difference
    0.2%
    Check dated 2026-09-06T22:31:22.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page now displays a new Revision: v3.6.6 tag. The topic labels were updated to remove Lung cancer, related topics:, MedlinePlus Genetics, and Revision: v3.6.5.
    Difference
    0.2%
    Check dated 2026-08-30T21:54:11.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    A new Revision: v3.6.5 label appears on the page. Several elements from the previous revision, including site listings, collaborator and sponsor details, and metadata such as dates and revision notes, have been removed or updated to reflect the new revision.
    Difference
    17%
    Check dated 2026-08-09T11:10:36.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page.